CD200 receptors are differentially expressed and modulated by minocycline in the brain during Trypanosoma brucei infection

Journal of Neuroimmunology

Volumn 226, Issue 1-2, 2010, Pages 59-65

  Masocha, Willias ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

CD200 receptors; Gene expression; Microglia; Minocycline; Neuroinflammation; Trypanosoma brucei

Indexed keywords

CD11B ANTIGEN; CD200 ANTIGEN; CD200 RECEPTOR; CD200 RECEPTOR LIKE A; CD200 RECEPTOR LIKE B; CD200 RECEPTOR LIKE C; MINOCYCLINE; UNCLASSIFIED DRUG; ANTIGENS, CD200; ANTIINFECTIVE AGENT; CD200 RECEPTOR, MOUSE; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA;

AFRICAN TRYPANOSOMIASIS; ANIMAL EXPERIMENT; ARTICLE; BRAIN INFECTION; CELL ACTIVATION; CONTROLLED STUDY; MACROPHAGE ACTIVATION; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; TRYPANOSOMA BRUCEI; ANIMAL; BRAIN; C57BL MOUSE; CLASSIFICATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; NONPARAMETRIC TEST; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; SPLEEN; TIME; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD; BRAIN; GENE EXPRESSION REGULATION; MACROPHAGE-1 ANTIGEN; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MINOCYCLINE; RNA, MESSENGER; SPLEEN; STATISTICS, NONPARAMETRIC; TIME FACTORS; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS;

EID: 77956339434     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.05.033     Document Type: Article

References (40)

1. Akkaya M., Barclay A.N. Heterogeneity in the CD200R paired receptor family. Immunogenetics 2009, 62(1):15-22.
2. Amin D.N., Masocha W., Ngan'dwe K., Rottenberg M., Kristensson K. Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion. Acta Trop. 2008, 106:72-74.
3. Bye N., Habgood M.D., Callaway J.K., Malakooti N., Potter A., Kossmann T., Morganti-Kossmann M.C. Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration. Exp. Neurol. 2007, 204:220-233.
4. Cai Z., Lin S., Fan L.W., Pang Y., Rhodes P.G. Minocycline alleviates hypoxic-ischemic injury to developing oligodendrocytes in the neonatal rat brain. Neuroscience 2006, 137:425-435.
5. Chianella S., Semprevivo M., Peng Z.C., Zaccheo D., Bentivoglio M., Grassi-Zucconi G. Microglia activation in a model of sleep disorder: an immunohistochemical study in the rat brain during Trypanosoma brucei infection. Brain Res. 1999, 832:54-62.
6. Chimelli L., Scaravilli F. Trypanosomiasis. Brain Pathol. 1997, 7:599-611.
7. Dumas M., Bisser S. Clinical aspects of human African trypanosomiasis. Progress in Human African Trypanosomiasis, Sleeping Sickness 1999, 215-233. Springer, Paris. M. Dumas, B. Bouteille, A. Buguet (Eds.).
8. Fan L.W., Pang Y., Lin S., Tien L.T., Ma T., Rhodes P.G., Cai Z. Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat. J. Neurosci. Res. 2005, 82:71-82.
9. Fan L.W., Lin S., Pang Y., Rhodes P.G., Cai Z. Minocycline attenuates hypoxia-ischemia-induced neurological dysfunction and brain injury in the juvenile rat. Eur. J. Neurosci. 2006, 24:341-350.
10. Gorczynski R.M., Chen Z., Clark D.A., Kai Y., Lee L., Nachman J., Wong S., Marsden P. Structural and functional heterogeneity in the CD200R family of immunoregulatory molecules and their expression at the feto-maternal interface. Am. J. Reprod. Immunol. 2004, 52:147-163.
11. Hatherley D., Cherwinski H.M., Moshref M., Barclay A.N. Recombinant CD200 protein does not bind activating proteins closely related to CD200 receptor. J. Immunol. 2005, 175:2469-2474.
12. Henry C.J., Huang Y., Wynne A., Hanke M., Himler J., Bailey M.T., Sheridan J.F., Godbout J.P. Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia. J. Neuroinflammation 2008, 5:15.
13. Herbert W.J., Lumsden W.H. Trypanosoma brucei: a rapid "matching" method for estimating the host's parasitemia. Exp. Parasitol. 1976, 40:427-431.
14. Irani D.N., Prow N.A. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J. Neuropathol. Exp. Neurol. 2007, 66:533-544.
15. Kennedy P.G. Diagnostic and neuropathogenesis issues in human African trypanosomiasis. Int. J. Parasitol. 2006, 36:505-512.
16. Kristensson K., Mhlanga J.D., Bentivoglio M. Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions. Curr. Top. Microbiol. Immunol. 2002, 265:227-257.
17. Liu B., Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J. Pharmacol. Exp. Ther. 2003, 304:1-7.
18. Liu Y., Bando Y., Vargas-Lowy D., Elyaman W., Khoury S.J., Huang T., Reif K., Chitnis T. CD200R1 agonist attenuates mechanisms of chronic disease in a murine model of multiple sclerosis. J. Neurosci. 2010, 30:2025-2038.
19. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
20. Manuelidis E.E., Robertson D.H., Amberson J.M., Polak M., Haymaker W. Trypanosoma rhodesiense encephalitis. Clinicopathological study of five cases of encephalitis and one of mel B hemorrhagic encephalopathy. Acta Neuropathol. (Berl.) 1965, 5:176-204.
21. Masocha W. Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain. J. Neuroimmunol. 2009, 214:78-82.
22. Masocha W., Robertson B., Rottenberg M.E., Mhlanga J., Sorokin L., Kristensson K. Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J. Clin. Invest. 2004, 114:689-694.
23. Masocha W., Rottenberg M.E., Kristensson K. Minocycline impedes African trypanosome invasion of the brain in a murine model. Antimicrob. Agents Chemother. 2006, 50:1798-1804.
24. Masocha W., Amin D.N., Kristensson K., Rottenberg M.E. Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL/6 and 129Sv/Ev mice. Scand. J. Immunol. 2008, 68:484-491.
25. Mihrshahi R., Barclay A.N., Brown M.H. Essential roles for Dok2 and RasGAP in CD200 receptor-mediated regulation of human myeloid cells. J. Immunol. 2009, 183:4879-4886.
26. Minas K., Liversidge J. Is the CD200/CD200 receptor interaction more than just a myeloid cell inhibitory signal?. Crit. Rev. Immunol. 2006, 26:213-230.
27. Mishra M.K., Basu A. Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J. Neurochem. 2008, 105:1582-1595.
28. Neumann H. Control of glial immune function by neurons. Glia 2001, 36:191-199.
29. Pepin J., Milord F. The treatment of human African trypanosomiasis. Adv. Parasitol. 1994, 33:1-47.
30. Rosenblum M.D., Woodliff J.E., Madsen N.A., McOlash L.J., Keller M.R., Truitt R.L. Characterization of CD 200-receptor expression in the murine epidermis. J. Investig. Dermatol. 2005, 125:1130-1138.
31. Tikka T.M., Vartiainen N.E., Goldsteins G., Oja S.S., Andersen P.M., Marklund S.L., Koistinaho J. Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease. Brain 2002, 125:722-731.
32. Voehringer D., Rosen D.B., Lanier L.L., Locksley R.M. CD200 receptor family members represent novel DAP12-associated activating receptors on basophils and mast cells. J. Biol. Chem. 2004, 279:54117-54123.
33. Wasserman J.K., Schlichter L.C. Minocycline protects the blood-brain barrier and reduces edema following intracerebral hemorrhage in the rat. Exp. Neurol. 2007, 207:227-237.
34. Wojtera M., Sikorska B., Sobow T., Liberski P.P. Microglial cells in neurodegenerative disorders. Folia Neuropathol. 2005, 43:311-321.
35. Wright G.J., Puklavec M.J., Willis A.C., Hoek R.M., Sedgwick J.D., Brown M.H., Barclay A.N. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity 2000, 13:233-242.
36. Wright G.J., Cherwinski H., Foster-Cuevas M., Brooke G., Puklavec M.J., Bigler M., Song Y., Jenmalm M., Gorman D., McClanahan T., Liu M.R., Brown M.H., Sedgwick J.D., Phillips J.H., Barclay A.N. Characterization of the CD200 receptor family in mice and humans and their interactions with CD200. J. Immunol. 2003, 171:3034-3046.
37. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl Acad. Sci. USA 1998, 95:15769-15774.
38. Yrjanheikki J., Tikka T., Keinanen R., Goldsteins G., Chan P.H., Koistinaho J. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl Acad. Sci. USA 1999, 96:13496-13500.
39. Zhang S., Phillips J.H. Identification of tyrosine residues crucial for CD200R-mediated inhibition of mast cell activation. J. Leukoc. Biol. 2006, 79:363-368.
40. Zhang S., Cherwinski H., Sedgwick J.D., Phillips J.H. Molecular mechanisms of CD200 inhibition of mast cell activation. J. Immunol. 2004, 173:6786-6793.